Efficacy of acetaminophen on preemptive multimodal analgesia in total knee arthroplasty: a prospective, double-blind, randomized placebo-controlled trial

Author:

Wang Qiuru1,Wang Zhuoer1,Ma Ting1,Wang Liying1,Zhao Chengcheng1,Kang Pengde1

Affiliation:

1. West China Hospital of Sichuan University

Abstract

Abstract BackgroundPreemptive multimodal analgesia is a commonly used method to control pain following total knee arthroplasty (TKA). This study aimed to evaluate the efficacy of preemptive acetaminophen for pain management in patients who underwent TKA.MethodsIn this prospective, double-blind, randomized placebo-controlled trial, 80 patients were randomized to the acetaminophen or control group. Patients in the acetaminophen group received celecoxib 400mg, pregabalin 150mg, and acetaminophen 325mg 2 hours before TKA. Patients in the control group received celecoxib, pregabalin, and placebo. Primary outcome was postoperative consumption of morphine hydrochloride used for rescue analgesia. Secondary outcomes included the time to the first rescue analgesia, postoperative pain as assessed by visual analogue scale (VAS), functional recovery as assessed by range of knee motion and ambulation distance, the time to hospital discharge, and complication rates.ResultsThere was no significant difference between the control group and the acetaminophen group in postoperative 0–24 h morphine consumption (average 11.3 mg vs. 12.3 mg, p = 0.445) and total morphine consumption (average 17.3 mg vs. 19.3 mg, p = 0.242). There was no significant difference in the time to the first rescue analgesia, postoperative VAS pain scores at any time points, postoperative functional recovery of knee, and the time to hospital discharge. The two groups had a similar occurrence of postoperative complications.ConclusionsThe addition of acetaminophen to preoperative preemptive multimodal analgesia could not reduce postoperative morphine consumption or improve pain relief. Orthopedic surgeons should reconsider routine use of preemptive acetaminophen in TKA.Trial registration: The study was prospectively registered on Chinese Clinical Trial Registry (identification number: ChiCTR2100052732) on 04/11/2021. http://www.chictr.org.cn/edit.aspx?pid=136730&htm=4

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3